Biotech firm Odyssey raises $279 million in upsized US IPO
08/05/2026 01:51
May 7 (Reuters) - Biopharmaceutical company Odyssey Therapeutics ODTX.O has raised $279 million in its upsized U.S. initial public offering, the company said on Thursday. (Reporting by Pragyan Kalita in Bengaluru; Editing by Subhranshu Sahu) ((Pragyan.Kalita@thomsonreuters.com;))